High costs and limited access threaten progress in HIV treatment despite new drug advances: GlobalData Read more
Diagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during 2024-34, forecasts GlobalData Read more
Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData Read more
PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis: GlobalData Read more
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024 Read more
KDCA, SK bioscience launch support programme to shield South Korea against future pandemic influenza threats Read more